Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Potassium Premedication in Symptomatic Irreversible Pulpitis
NCT07743372Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2026
- Primary completion
- Aug 2027
01
Overview
Randomised trial of diclofenac in irreversible pulpitis (3 arms), sponsored by Cairo University. Primary endpoint: Anesthetic success of articaine buccal infiltration at 0 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
diclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07743372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743372.